Kyle L. MacQuarrie

Kyle L. MacQuarrie

Auto-generated profile, based on publicly available information

Kyle L. MacQuarrie

Stanley Manne Children's Research Institute Ann and Robert H. Lurie Children's Hospital of Chicago Chicago IL 60611 USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Developmental Cell
Verified
Journal Article
Closed access
YCYi Cao
Yi Cao
ZYZizhen Yao
Zizhen Yao
DSDeepayan Sarkar
Deepayan Sarkar
MLMichael Lawrence
Michael Lawrence
GSGilson J. Sanchez
Gilson J. Sanchez
STStephen J. Tapscott
Stephen J. Tapscott

1 April 2011 in Trends in Genetics
Verified
Journal Article
Closed access
KMKyle L. MacQuarrie
Kyle L. MacQuarrie
AFAbraham P. Fong
Abraham P. Fong
RMRandall H. Morse
Randall H. Morse
STStephen J. Tapscott
Stephen J. Tapscott

30 September 2009 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
BMBradley J. Molyneaux
Bradley J. Molyneaux
PAPaola Arlotta
Paola Arlotta
RFRyann M Fame
Ryann M Fame
JMJessica MacDonald
Jessica MacDonald
KMKyle L. MacQuarrie
Kyle L. MacQuarrie
JMJeffrey D. Macklis
Jeffrey D. Macklis
Little is known about the molecular development and heterogeneity of callosal projection neurons (CPN), cortical commissural neurons that connect homotopic regions of the two cerebral hemispheres via the corpus callosum and that are critical for bilateral integration of cortical information. Here we report on the identification of a series of genes that individually and in combination define CPN and novel CPN subpopulations during embryonic and postnatal development. We usedin situhybridization analysis, immunocytochemistry, and retrograde labeling to define the layer-specific and neuron-type-specific distribution of these newly identified CPN genes across different stages of maturation. We demonstrate that a subset of these genes (e.g.,Hspb3andLpl) appear specific to all CPN (in layers II/III and V–VI), whereas others (e.g.,Nectin-3,Plexin-D1, andDkk3) discriminate between CPN of the deep layers and those of the upper layers. Furthermore, the data show that several genes finely subdivide CPN within individual layers and appear to label CPN subpopulations that have not been described previously using anatomical or morphological criteria. The genes identified here likely reflect the existence of distinct programs of gene expression governing the development, maturation, and function of the newly identified subpopulations of CPN. Together, these data define the first set of genes that identify and molecularly subcategorize distinct populations of callosal projection neurons, often located in distinct subdivisions of the canonical cortical laminae.

15 March 2009 in Genes & Development
Verified
Journal Article
Closed access
PDF file
ZYZhihong Yang
Zhihong Yang
KMKyle L. MacQuarrie
Kyle L. MacQuarrie
EAErwin Analau
Erwin Analau
ATAshlee E. Tyler
Ashlee E. Tyler
FDF. Jeffery Dilworth
F. Jeffery Dilworth
STStephen J. Tapscott
Stephen J. Tapscott
Rhabdomyosarcomas are characterized by expression of myogenic specification genes, such as MyoD and/or Myf5, and some muscle structural genes in a population of cells that continues to replicate. Because MyoD is sufficient to induce terminal differentiation in a variety of cell types, we have sought to determine the molecular mechanisms that prevent MyoD activity in human embryonal rhabdomyosarcoma cells. In this study, we show that a combination of inhibitory Musculin:E-protein complexes and a novel splice form of E2A compete with MyoD for the generation of active full-length E-protein:MyoD heterodimers. A forced heterodimer between MyoD and the full-length E12 robustly restores differentiation in rhabdomyosarcoma cells and broadly suppresses multiple inhibitory pathways. Our studies indicate that rhabdomyosarcomas represent an arrested progress through a normal transitional state that is regulated by the relative abundance of heterodimers between MyoD and the full-length E2A proteins. The demonstration that multiple inhibitory mechanisms can be suppressed and myogenic differentiation can be induced in the RD rhabdomyosarcomas by increasing the abundance of MyoD:E-protein heterodimers suggests a central integrating function that can be targeted to force differentiation in muscle cancer cells.

1 February 2013 in Molecular and Cellular Biology
Verified
Journal Article
Open access
PDF file
KMKyle L. MacQuarrie
Kyle L. MacQuarrie
ZYZizhen Yao
Zizhen Yao
AFAbraham P. Fong
Abraham P. Fong
SDScott J. Diede
Scott J. Diede
ERErin R. Rudzinski
Erin R. Rudzinski
STStephen J. Tapscott
Stephen J. Tapscott
Rhabdomyosarcoma is a pediatric tumor of skeletal muscle that expresses the myogenic basic helix-loop-helix protein MyoD but fails to undergo terminal differentiation. Prior work has determined that DNA binding by MyoD occurs in the tumor cells, but myogenic targets fail to activate. Using MyoD chromatin immunoprecipitation coupled to high-throughput sequencing and gene expression analysis in both primary human muscle cells and RD rhabdomyosarcoma cells, we demonstrate that MyoD binds in a similar genome-wide pattern in both tumor and normal cells but binds poorly at a subset of myogenic genes that fail to activate in the tumor cells. Binding differences are found both across genomic regions and locally at specific sites that are associated with binding motifs for RUNX1, MEF2C, JDP2, and NFIC. These factors are expressed at lower levels in RD cells than muscle cells and rescue myogenesis when expressed in RD cells. MEF2C is located in a genomic region that exhibits poor MyoD binding in RD cells, whereas JDP2 exhibits local DNA hypermethylation in its promoter in both RD cells and primary tumor samples. These results demonstrate that regional and local silencing of differentiation factors contributes to the differentiation defect in rhabdomyosarcomas.

10 January 2025 in Science Advances
Verified
Journal Article
Open access
LALuay M. Almassalha
Luay M. Almassalha
MCMarcelo Carignano
Marcelo Carignano
ELEmily Pujadas Liwag
Emily Pujadas Liwag
WLWing Shun Li
Wing Shun Li
RGRuyi Gong
Ruyi Gong
VBVadim Backman
Vadim Backman
In single cells, variably sized nanoscale chromatin structures are observed, but it is unknown whether these form a cohesive framework that regulates RNA transcription. Here, we demonstrate that the human genome is an emergent, self-assembling, reinforcement learning system. Conformationally defined heterogeneous, nanoscopic packing domains form by the interplay of transcription, nucleosome remodeling, and loop extrusion. We show that packing domains are not topologically associated domains. Instead, packing domains exist across a structure-function life cycle that couples heterochromatin and transcription in situ, explaining how heterochromatin enzyme inhibition can produce a paradoxical decrease in transcription by destabilizing domain cores. Applied to development and aging, we show the pairing of heterochromatin and transcription at myogenic genes that could be disrupted by nuclear swelling. In sum, packing domains represent a foundation to explore the interactions of chromatin and transcription at the single-cell level in human health.